- Apr 2, 2009
- 5,171
- 13,288
- 67
Last Thursday, more than a dozen tobacco harm reduction advocates (including many CASAA members) presented during the public comment period of the FDA's TPSAC meeting on dissolvable tobacco products in Rockville, MD.
More than a half dozen CASAA members told FDA and its TPSAC that they quit smoking by switching to e-cigarettes and/or other smokefree alternatives, while I and other harm reduction advocates urged the FDA and its TPSAC to truthfully inform the public that dissolvables and other smokefree tobacco products are far less hazardoud alternatives for cigarette smokers (in TPSAC's forthcoming report).
The public comment period begins at 5:20 (i.e. 5 hours, 20 minutes into the meeting) of the archived video at
https://collaboration.fda.gov/p49817128/
I suggest that all e-cigarette and tobacco harm reduction advocates watch/listen to these public comments, and to the Q & A by FDA and TPSAC members.
The three day TPSAC meeting can be seen/heard at:
January 18: [URL]https://collaboration.fda.gov/p24943709/[/URL]
January 19: https://collaboration.fda.gov/p49817128/
January 20: https://collaboration.fda.gov/p36812959/
More than a half dozen CASAA members told FDA and its TPSAC that they quit smoking by switching to e-cigarettes and/or other smokefree alternatives, while I and other harm reduction advocates urged the FDA and its TPSAC to truthfully inform the public that dissolvables and other smokefree tobacco products are far less hazardoud alternatives for cigarette smokers (in TPSAC's forthcoming report).
The public comment period begins at 5:20 (i.e. 5 hours, 20 minutes into the meeting) of the archived video at
https://collaboration.fda.gov/p49817128/
I suggest that all e-cigarette and tobacco harm reduction advocates watch/listen to these public comments, and to the Q & A by FDA and TPSAC members.
The three day TPSAC meeting can be seen/heard at:
January 18: [URL]https://collaboration.fda.gov/p24943709/[/URL]
January 19: https://collaboration.fda.gov/p49817128/
January 20: https://collaboration.fda.gov/p36812959/